<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">DNA vaccination confers an attractive approach for developing a SARS vaccine due to their simplicity, stability, safety and easy production ability as compared to other conventional approach. In the field of DNA vaccination substantial progress have been recorded in the past decades with the production of HIV-1 vaccines (the first DNA vaccine) demonstrated in human, which depicts the safety and protective efficacy of the vaccine [
 <xref rid="bb0165" ref-type="bibr">33</xref>]. Besides this various other DNA vaccines including AIDS [
 <xref rid="bb0170" ref-type="bibr">34</xref>], malaria and influenza [
 <xref rid="bb0175" ref-type="bibr">35</xref>] are also under human trial.
</p>
